The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
The NAD metabolome — a key determinant of cancer cell biology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
(1998) · National Academies Press eBooks · doi:10.17226/6015 · Cited by 2,435
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J., Huss, J. W., et al. (2009) · Genome Biology · doi:10.1186/gb-2009-10-11-r130 · Cited by 1,374
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J.-K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,190
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010
Fong, P. C., Yap, T. A., Boss, D. S., Carden, C. P., Mergui-Roelvink, M., Gourley, C., De Greve, J., Lubinski, J., Shanley, S., Messiou, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9589 · Cited by 1,010
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.041 · Cited by 1,001
Sundaresan, N. R., Gupta, M., Kim, G., Rajamohan, S. B., Isbatan, A., & Gupta, M. P. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39162 · Cited by 995
NAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., & Sternglanz, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110148297 · Cited by 970
Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., Lamming, D. W., Souza-Pinto, N. C., Bohr, V. A., Rosenzweig, A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.035 · Cited by 950
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914
Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S.-H., Jiang, H., Kim, H.-S., Flynn, C. R., Hill, S., Hayes McDonald, W., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.12.013 · Cited by 899
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
SIRT6 Promotes DNA Repair Under Stress by Activating PARP1
Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., & Gorbunova, V. (2011) · Science · doi:10.1126/science.1202723 · Cited by 867
Helleday, T. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.001 · Cited by 856
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
Hallows, W. C., Lee, S., & Denu, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604392103 · Cited by 792
Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.023 · Cited by 785
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.001 · Cited by 769
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Smith, J. S., Brachmann, C. B., Celic, I., Kenna, M. A., Muhammad, S., Starai, V. J., Avalos, J. L., Escalante-Semerena, J. C., Grubmeyer, C., Wolberger, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6658 · Cited by 718
Bogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 620
Hasmann, M., & Schemainda, I. (2003) · PubMed · Cited by 617
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588
Hassa, P. (2008) · Frontiers in Bioscience · doi:10.2741/2909 · Cited by 584
Rongvaux, A., Shea, R. J., Mulks, M. H., Gigot, D., Urbain, J., Leo, O., & Andris, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3225::aid-immu3225>3.0.co;2-l · Cited by 548
Honjo, T., Nishizuka, Y., Hayaishi, O., & Kato, I. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93347-8 · Cited by 537
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Kim, H.-S., Vassilopoulos, A., Wang, R.-H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.004 · Cited by 537
The dynamic regulation of NAD metabolism in mitochondria
Stein, L. R., & Imai, S.-I. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.005 · Cited by 535
Berger, F., Lau, C., Dahlmann, M., & Ziegler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508660200 · Cited by 508
Self-citationDBC1 is a negative regulator of SIRT1
Kim, J.-E., Chen, J., & Lou, Z. (2008) · Nature · doi:10.1038/nature06500 · Cited by 505
The new life of a centenarian: signalling functions of NAD(P)
Berger, F. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.01.007 · Cited by 489
Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
Gilley, J., & Coleman, M. P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000300 · Cited by 472
Negative regulation of the deacetylase SIRT1 by DBC1
Zhao, W., Kruse, J.-P., Tang, Y., Jung, S. Y., Qin, J., & Gu, W. (2008) · Nature · doi:10.1038/nature06515 · Cited by 466
Intracellular Coenzymes as Natural Biomarkers for Metabolic Activities and Mitochondrial Anomalies
Heikal, A. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.1 · Cited by 458
Bell, E. L., Emerling, B. M., Ricoult, S. J. H., & Guarente, L. (2011) · Oncogene · doi:10.1038/onc.2011.37 · Cited by 440
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Cantó, C., & Auwerx, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003905 · Cited by 433
Conserved Metabolic Regulatory Functions of Sirtuins
Schwer, B., & Verdin, E. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.006 · Cited by 415
Kraus, W. L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.03.006 · Cited by 409
Biosynthesis of Diphosphopyridine Nucleotide
Preiss, J., & Handler, P. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64790-8 · Cited by 407
Biosynthesis of Diphosphopyridine Nucleotide
Preiss, J., & Handler, P. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64789-1 · Cited by 403
Nampt: linking NAD biology, metabolism and cancer
Garten, A., Petzold, S., Körner, A., Imai, S.-I., & Kiess, W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.10.004 · Cited by 398
Pillai, J. B., Isbatan, A., Imai, S.-I., & Gupta, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506162200 · Cited by 391
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Wang, R.-H., Zheng, Y., Kim, H.-S., Xu, X., Cao, L., Lahusen, T., Lee, M.-H., Xiao, C., Vassilopoulos, A., Chen, W., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.011 · Cited by 359
Mészáros, L. G., Bak, J., & Chu, A. (1993) · Nature · doi:10.1038/364076a0 · Cited by 357
Sirtuins mediate mammalian metabolic responses to nutrient availability
Chalkiadaki, A., & Guarente, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.225 · Cited by 346
Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells
Nikiforov, A., Dölle, C., Niere, M., & Ziegler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213298 · Cited by 326
Self-citationSIRT1, Is It a Tumor Promoter or Tumor Suppressor?
Deng, C.-X. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.147 · Cited by 321
Poly(ADP‐ribose): The most elaborate metabolite of NAD+
Bürkle, A. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04864.x · Cited by 294
Holen, K., Saltz, L. B., Hollywood, E., Burk, K., & Hanauske, A.-R. (2008) · Investigational New Drugs · doi:10.1007/s10637-007-9083-2 · Cited by 293
Harnessing synthetic lethal interactions in anticancer drug discovery
Chan, D. A., & Giaccia, A. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3374 · Cited by 262
Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C. G. T., Kurimasa, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.029 · Cited by 260
SIRT1: recent lessons from mouse models
Herranz, D., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2962 · Cited by 255
Altered sirtuin expression is associated with node-positive breast cancer
Ashraf, N., Zino, S., MacIntyre, A., Kingsmore, D., Payne, A. P., George, W. D., & Shiels, P. G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603384 · Cited by 248
Wang, B., Hasan, M. K., Alvarado, E., Yuan, H., Wu, H., & Chen, W. Y. (2011) · Oncogene · doi:10.1038/onc.2010.468 · Cited by 245
Huang, J.-Y., Hirschey, M. D., Shimazu, T., Ho, L., & Verdin, E. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.12.021 · Cited by 231
Watson, M., Roulston, A., Bélec, L., Billot, X., Marcellus, R., Bédard, D., Bernier, C., Branchaud, S., Chan, H., Dairi, K., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00112-09 · Cited by 229
CD38 and chronic lymphocytic leukemia: a decade later
Malavasi, F., Deaglio, S., Damle, R., Cutrona, G., Ferrarini, M., & Chiorazzi, N. (2011) · Blood · doi:10.1182/blood-2011-06-275610 · Cited by 224
Jackson, M. D., & Denu, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200671200 · Cited by 212
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic
Yap, T. A., Sandhu, S. K., Carden, C. P., & de Bono, J. S. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20095 · Cited by 208
von Heideman, A., Berglund, Å., Larsson, R., & Nygren, P. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1125-3 · Cited by 201
Nampt/PBEF/visfatin and cancer
Bi, T.-Q., & Che, X.-M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.2.12581 · Cited by 197
Chini, E. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185788 · Cited by 189
Chen, J., Zhang, B., Wong, N., Lo, A. W. I., To, K.-F., Chan, A. W. H., Ng, M. H. L., Ho, C. Y. S., Cheng, S.-H., Lai, P. B. S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4274 · Cited by 188
SIRT3 and cancer: Tumor promoter or suppressor?
Alhazzazi, T. Y., Kamarajan, P., Verdin, E., & Kapila, Y. L. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.04.004 · Cited by 180
Branster, M. V., & Morton, R. K. (1956) · Biochemical Journal · doi:10.1042/bj0630640 · Cited by 174
Chromatin regulation and genome maintenance by mammalian SIRT6
Tennen, R. I., & Chua, K. F. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.009 · Cited by 164
Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis
Tong, W.-M., Cortes, U., & Wang, Z.-Q. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00035-x · Cited by 163
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Kim, S.-R., Bae, S., Choi, K., Park, S.-Y., Jun, H. O., Lee, J. Y., Jang, H., Yun, I., Yoon, K., Kim, Y.-J., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.105 · Cited by 156
Warburg Effect and Redox Balance
Hamanaka, R. B., & Chandel, N. S. (2011) · Science · doi:10.1126/science.1215637 · Cited by 154
Biosynthesis of Diphosphopyridine Nucleotide
Imsande, J., & Handler, P. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64397-2 · Cited by 149
SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells
Meter, M. V., Mao, Z., Gorbunova, V. A., & Seluanov, A. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17435 · Cited by 140
The NMN/NaMN adenylyltransferase (NMNAT) protein family
Lau, C., Niere, M., & Ziegler, M. (2009) · Frontiers in bioscience · doi:10.2741/3252 · Cited by 136
Self-citationPharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis
Pittelli, M. G., Felici, R., Pitozzi, V., Giovannelli, L., Bigagli, E., Cialdai, F., Romano, G., Moroni, F., & Chiarugi, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073916 · Cited by 132
Self-citationNicotinamide Phosphoribosyltransferase in Human Diseases
Zhang, L. Q., Heruth, D. P., & Ye, S. Q. (2011) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000038 · Cited by 129
Identification of a novel human nicotinamide mononucleotide adenylyltransferase
Raffaelli, N., Sorci, L., Amici, A., Emanuelli, M., Mazzola, F., & Magni, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02285-4 · Cited by 127
Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Calcium Signaling
Lee, H. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500012200 · Cited by 122
Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose
Tong, L., & Denu, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.02.007 · Cited by 122
A Phase I study of CHS 828 in patients with solid tumor malignancy.
Hovstadius, P., Larsson, R. L., Jonsson, E., Skov, T., Kissmeyer, A., Krasilnikoff, K., Bergh, J. C. S., Karlsson, M. O., Lönnebo, A., & Ahlgren, J. (2002) · PubMed · Cited by 119
Hara, N., Yamada, K., Shibata, T., Osago, H., & Tsuchiya, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022781 · Cited by 116
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
Lukasova, M., Hanson, J., Tunaru, S., & Offermanns, S. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.08.002 · Cited by 112
Magnitude and significance of NAD turnover in human cell line D98/AH2
Rechsteiner, M., Hillyard, D. R., & Olivera, B. M. (1976) · Nature · doi:10.1038/259695a0 · Cited by 111
Berger, F., Lau, C., & Ziegler, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609211104 · Cited by 111
Self-citationZhang, T., Berrocal, J. G., Yao, J., DuMond, M. E., Krishnakumar, R., Ruhl, D. D., Ryu, K. W., Gamble, M. J., & Kraus, W. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304469 · Cited by 111
Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases
Koch‐Nolte, F., Kernstock, S., Mueller‐Dieckmann, C., Weiss, M. S., & Haag, F. (2008) · Frontiers in bioscience · doi:10.2741/3184 · Cited by 108
Ravaud, A., Cerny, T., Terret, C., Wanders, J., Bui, B., Hess, D., Droz, J., Fumoleau, P., & Twelves, C. J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.023 · Cited by 105
Enzymic Synthesis of Coenzyme I in Relation to Chemical Control of Cell Growth
Morton, R. K. (1958) · Nature · doi:10.1038/181540a0 · Cited by 103
Are poly(ADP‐ribosyl)ation by PARP‐1 and deacetylation by Sir2 linked?
Zhang, J. (2003) · BioEssays · doi:10.1002/bies.10317 · Cited by 99
Decreased cADPR and increased NAD+ in the Cd38−/− mouse
Young, G. S., Choleris, E., Lund, F. E., & Kirkland, J. B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.100 · Cited by 94
Enzymology of mammalian NAD metabolism in health and disease
Magni, G., Orsomando, G., Raffelli, N., & Ruggieri, S. (2008) · Frontiers in bioscience · doi:10.2741/3143 · Cited by 93
How to kill tumor cells with inhibitors of poly(ADP‐ribosyl)ation
Mangerich, A., & Bürkle, A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25683 · Cited by 85
NAD depletion by FK866 induces autophagy
Billington, R. A., Genazzani, A. A., Travelli, C., & Condorelli, F. (2008) · Autophagy · doi:10.4161/auto.5635 · Cited by 79
de Nigris, F., Cerutti, J. M., Morelli, C., Califano, D., Chiariotti, L., Viglietto, G., Santelli, G., & Fusco, A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600636 · Cited by 78
Pathway analysis of NAD+ metabolism
de Figueiredo, L. F., Gossmann, T. I., Ziegler, M., & Schuster, S. (2011) · Biochemical Journal · doi:10.1042/bj20110320 · Cited by 69
Self-citationPreclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777
Beauparlant, P., Bédard, D., Bernier, C., Chan, H. H. L., Gilbert, K., Goulet, D., Gratton, M., Lavoie, M., Roulston, A., Turcotte, É., et al. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283287c20 · Cited by 67
Drevs, J., Löser, R., Rattel, B., & Esser, N. (2003) · PubMed · Cited by 65
Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound
Fleischer, T. C., Murphy, B. R., Flick, J. S., Terry-Lorenzo, R. T., Gao, Z.-H., Davis, T., McKinnon, R. S., Ostanin, K., Willardsen, J. A., & Boniface, J. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.008 · Cited by 54
NAD+ biosynthesis and salvage – a phylogenetic perspective
Gossmann, T. I., Ziegler, M., Puntervoll, P., de Figueiredo, L. F., Schuster, S., & Heiland, I. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08559.x · Cited by 52
Self-citationThe clinical development of inhibitors of poly(ADP-ribose) polymerase
Calvert, H., & Azzariti, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq667 · Cited by 52
‘SIRT8’ expressed in thyroid cancer is actually SIRT7
Frye, R. A. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600635 · Cited by 50
ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis
Kato, J., Zhu, J., Liu, C., Stylianou, M. P., Hoffmann, V. J., Lizak, M. J., Glasgow, C. G., & Moss, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0733 · Cited by 49
Stevenson, G. T. (2006) · Molecular Medicine · doi:10.2119/2006-00082.stevenson · Cited by 46
A snapshot of chemoresistance to PARP inhibitors
Chiarugi, A. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.10.001 · Cited by 43
Self-citationTravelli, C., Drago, V., Maldi, E., Kaludercic, N., Galli, U., Boldorini, R. L., Lisa, F. D., Tron, G. C., Canonico, P. L., & Genazzani, A. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184630 · Cited by 43
Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
Garten, A., Petzold-Quinque, S., Schuster, S., Körner, A., Kratzsch, J., & Kieß, W. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_7 · Cited by 42
Control of the steady-state concentrations of the nicotinamide nucleotides in rat liver
Clark, J. B., & Pinder, S. (1969) · Biochemical Journal · doi:10.1042/bj1140321 · Cited by 39
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
Papeo, G., Forte, B., Orsini, P., Perrera, C., Posteri, H., Scolaro, A., & Montagnoli, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903215883 · Cited by 38
Petrelli, R., Felczak, K., & Cappellacci, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795590048 · Cited by 37
Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma
Kato, H., Ito, E., Shi, W., Alajez, N. M., Yue, S., Lee, C., Chan, N. H. L., Bhogal, N., Coackley, C. L., Vines, D., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1945 · Cited by 37
Biochemical mechanisms of resistance to tiazofurin
Jayaram, H. N. (1985) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(85)90070-6 · Cited by 31
Players in the PARP-1 cell-death pathway: JNK1 joins the cast
Alano, C. C., & Swanson, R. A. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.04.006 · Cited by 29
Tiazofurine ICN Pharmaceuticals.
Grifantini, M. (2000) · PubMed · Cited by 22
Cited by
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708
Emerging roles of lipid metabolism in cancer metastasis
Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0646-3 · Cited by 677
Metadata
- Authors
- Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M.
- Venue
- Nature Reviews Cancer
- Published
- 2012-09-28
- Volume
- 12
- Issue
- 11
- Pages
- 741-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2012538520
- Cited by
- 639
- References
- 132
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.